Skip to main content
Premium Trial:

Request an Annual Quote

Sciex, Mass Consortium Ink Software Reseller Agreement

NEW YORK (GenomeWeb) – Sciex has signed an agreement with Mass Consortium, a mass spectrometry-focused software company, for exclusive reseller and marketing rights to the company's XCMSplus software.

The XCMSplus software is a personal cloud version of Mass Consortium's XCMS Online, a solution developed at the Scripps Research Institute for analyzing metabolomics data. XCMSplus offers improved multi-group analysis capabilities, faster on-site data processing, and local data storage and sharing capabilities. It lets researchers simplify and accelerate their metabolomics workflows by providing tools for processing, visualizing, and analyzing data in one interactive, secure bioinformatics environment.

Gary Siuzdak, a professor and director of the Scripps Center for Metabolomics, described XCMSplus as a "natural fit" for Sciex's instrument platforms. "Beyond XCMS's robust data processing and visualization features, virtually the entire metabolomic community can privately — and publicly — share their data and results within the XCMSplus personal data cloud," he said in a statement. "This makes XCMSplus and Sciex an ideal, integrated platform for the highly collaborative metabolomic community."

"As high-speed, high-resolution SCIEX mass spectrometers are needed to deliver higher quality metabolomics, the rapid acquisition of Big Data is becoming the norm," Aaron Hudson, senior director of academic and clinical research business of Sciex, added. "XCMSplus is designed for this rapid acquisition with a robust set of algorithms to align features, identify peaks, perform statistical tests, and visualize complex results."

Financial and other terms of the agreement were not disclosed.


The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.